$8.16 -0.51 (-5.88%)
11/27/2009 1:00 PM

BioCryst Pharmaceuticals, Inc. (BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Featured Broker Partners